Skip to main content

Table 1 Demographic data (n = 50)

From: Efficacy of silver needle therapy for the treatment of chronic nonspecific low back pain: a prospective, single-center, randomized, parallel-controlled clinical trial

 

Control group

Silver needle group

Female/male (number)

26/24

28/22

Age (year)

48.9 ± 14.3

50.8 ± 15.3

BMI (kg/m2)

24.3 ± 3.0

24.8 ± 2.4

ASA grade

 I

28

24

 II

15

20

 III

7

6

NRS score

8.02 ± 0.80

7.90 ± 0.91

ODI score

64.8 ± 2.8

65.6 ± 2.7

SF-12 score

19.7 ± 3.0

19.0 ± 3.3

Bioelectricity score

60.6 ± 4.4

60.4 ± 3.4

InLF (In (ms2))

4.03 ± 0.59

3.99 ± 0.66

InHF (In (ms2))

3.42 ± 0.56

3.39 ± 0.59

LF/HF

1.85 ± 0.27

1.84 ± 0.26

  1. The demographic data of patients in the two groups had no significant difference
  2. BMI body mass index, ASA American Society of Anesthesiologists, NRS numerical rating scale, ODI Oswestry Disability Index, SF-12 Short-Form 12 of quality of life, lnLF natural logarithms of the low frequency measurement, lnHF natural logarithms of the high frequency measurement, LF/HF low frequency/high frequency ratio
Back to article page

Trials

ISSN: 1745-6215